As far as SPC extensions are concerned, national patent offices in 16 Member States had, by the end of 2011, granted 6-month extensions to 11 medicinal products, which resulted in a total of more than 100 national SPCs.
En ce qui concerne les prorogations du CCP, les offices nationaux des brevets de 16 États membres avaient accordé, fin 2011, une prorogation de six mois à 11 médicaments, pour un total de plus de 100 CCP nationaux.